Fang F - Search Results

1

Juglone promotes antitumor activity against prostate cancer via suppressing glycolysis and oxidative phosphorylation.

Hu C, Xu H, Li Z, Liu D, Zhang S, Fang F, Wang L. Hu C, et al. Among authors: fang f. Phytother Res. 2023 Feb;37(2):515-526. doi: 10.1002/ptr.7631. Epub 2022 Oct 24. Phytother Res. 2023. PMID: 36281060

2

Inhibition of CD147 expression reduces tumor cell invasion in human prostate cancer cell line via RNA interference.

Wang L, Wu G, Yu L, Yuan J, Fang F, Zhai Z, Wang F, Wang H. Wang L, et al. Among authors: fang f. Cancer Biol Ther. 2006 Jun;5(6):608-14. doi: 10.4161/cbt.5.6.2661. Epub 2006 Jun 5. Cancer Biol Ther. 2006. PMID: 16627983 Free article.

3

CD147 modulates autophagy through the PI3K/Akt/mTOR pathway in human prostate cancer PC-3 cells.

Fang F, Wang L, Zhang S, Fang Q, Hao F, Sun Y, Zhao L, Chen S, Liao H, Wang L. Fang F, et al. Among authors: fang q. Oncol Lett. 2015 Mar;9(3):1439-1443. doi: 10.3892/ol.2015.2849. Epub 2015 Jan 5. Oncol Lett. 2015. PMID: 25663928 Free PMC article.

4

Juglone exerts antitumor effect in ovarian cancer cells.

Fang F, Qin Y, Qi L, Fang Q, Zhao L, Chen S, Li Q, Zhang D, Wang L. Fang F, et al. Among authors: fang q. Iran J Basic Med Sci. 2015 Jun;18(6):544-8. Iran J Basic Med Sci. 2015. PMID: 26221477 Free PMC article.

5

CD147 modulates androgen receptor activity through the Akt/Gsk-3β/β-catenin/AR pathway in prostate cancer cells.

Fang F, Qin Y, Hao F, Li Q, Zhang W, Zhao C, Chen S, Zhao L, Wang L, Cai J. Fang F, et al. Oncol Lett. 2016 Aug;12(2):1124-1128. doi: 10.3892/ol.2016.4684. Epub 2016 Jun 7. Oncol Lett. 2016. PMID: 27446405 Free PMC article.

6

Juglone suppresses epithelial-mesenchymal transition in prostate cancer cells via the protein kinase B/glycogen synthase kinase-3β/Snail signaling pathway.

Fang F, Chen S, Ma J, Cui J, Li Q, Meng G, Wang L. Fang F, et al. Oncol Lett. 2018 Aug;16(2):2579-2584. doi: 10.3892/ol.2018.8885. Epub 2018 Jun 4. Oncol Lett. 2018. PMID: 30013652 Free PMC article.

7

CD147 promotes epithelial-mesenchymal transition of prostate cancer cells via the Wnt/β-catenin pathway.

Fang F, Li Q, Wu M, Nie C, Xu H, Wang L. Fang F, et al. Exp Ther Med. 2020 Oct;20(4):3154-3160. doi: 10.3892/etm.2020.9058. Epub 2020 Jul 28. Exp Ther Med. 2020. PMID: 32855684 Free PMC article.

8

[Proliferation inhibition and apoptosis induction of Juglone on human cervical cancer Caski cells].

Zhang W, Li Y, Luo J, Zhao X, Xu J, Zhu W, Jiang Y, Fang F. Zhang W, et al. Among authors: fang f. Wei Sheng Yan Jiu. 2014 Nov;43(6):959-61, 971. Wei Sheng Yan Jiu. 2014. PMID: 25603606 Chinese.

9

Gut microbiota: A novel and potential target for radioimmunotherapy in colorectal cancer.

Yuan H, Gui R, Wang Z, Fang F, Zhao H. Yuan H, et al. Among authors: fang f. Front Immunol. 2023 Jan 31;14:1128774. doi: 10.3389/fimmu.2023.1128774. eCollection 2023. Front Immunol. 2023. PMID: 36798129 Free PMC article. Review.

10

MiR-138 Suppresses the PDK1 Expression to Decrease the Oxaliplatin Resistance of Colorectal Cancer.

Wang Y, Zhang D, Li Y, Fang F. Wang Y, et al. Among authors: fang f. Onco Targets Ther. 2020 Apr 29;13:3607-3618. doi: 10.2147/OTT.S242929. eCollection 2020. Onco Targets Ther. 2020. PMID: 32431512 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,890 results

Search Page

Filters